GE HealthCare Technologies Inc - Company Profile
Powered by 
All the data and insights you need on GE HealthCare Technologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date GE HealthCare Technologies Inc Strategy Report
- Understand GE HealthCare Technologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreGE HealthCare Technologies Inc (GE HealthCare), is a medical technology, pharmaceutical diagnostics, and digital solutions company. It designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing, and cellular technologies; imaging agents used during medical scanning procedures; and healthcare IT solutions. GE HealthCare also provides services such as performance improvement and performance solutions services, computerized data management, and remote diagnostic and repair services of medical equipment manufactured by the company and others. The company conducts its operations across the world through subsidiaries and affiliates. GE HealthCare is headquartered in Chicago, Illinois, the US.
Headquarters
United States of America
Address
500 West Monroe Street, Chicago, Illinois, 60661
Website
www.gehealthcare.com
Telephone
1 203 3604369
No of Employees
51,000
Industry
Medical Equipment
Ticker Symbol & Exchange
GEHC (NASD)
Revenue (2022)
$19.6B
6.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-18.2%
(2022 vs 2021)
Market Cap*
$37.4B
Net Profit Margin (2022)
XYZ
-23.3%
(2022 vs 2021)
* As of and is in US$
GE HealthCare Technologies Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Imaging: | Expert Services Delivery: | Pixxoscan |
| Bone & Metabolic Health | Service Contracts | Signa Magnus |
| Fluoroscopy | Customer Support | Revolution Maxima |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | New Product Approvals | In May, the company launched Signa Magnus. |
| 2024 | Contracts/Agreements | In May, the company and MedStar Health in collaboration with the National Basketball Association, the National Basketball Players Association, and the Next Gen Basketball Players Union concluded the data collection phase of a longitudinal pilot study of NBA G League players. |
| 2024 | Contracts/Agreements | In May, the company partnered with Medis Medical Imaging to help advance precision care in the diagnosis and treatment of coronary artery disease. |
Competitor Comparison
| Key Parameters | GE HealthCare Technologies Inc | Bayer AG | Siemens Healthineers AG | Shenzhen Mindray Bio-Medical Electronics Co Ltd | Bracco SpA |
|---|---|---|---|---|---|
| Headquarters | United States of America | Germany | Germany | China | Italy |
| City | Chicago | Leverkusen | Forchheim | Shenzhen | Milan |
| State/Province | Illinois | Nordrhein-Westfalen | - | Guangdong | Lombardia |
| No. of Employees | 51,000 | 98,189 | 71,800 | 18,044 | 3,647 |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| H. Lawrence Culp, Jr | Chairman | Executive Board | 2023 | 61 |
| Peter J. Arduini | Chief Executive Officer; Director; President | Executive Board | 2023 | 59 |
| James K. Saccaro | Vice President; Chief Financial Officer | Senior Management | 2023 | 51 |
| Brian Montgomery | Chief Strategy Officer | Senior Management | 2020 | - |
| Jahid Khandaker | Chief Information Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer